Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles
AUTOR(ES)
Schoch, Claudia
FONTE
The National Academy of Sciences
RESUMO
Acute myeloid leukemia (AML) is a heterogeneous group of genetically defined diseases. Their classification is important with regard to prognosis and treatment. We performed microarray analyses for gene expression profiling on bone marrow samples of 37 patients with newly diagnosed AML. All cases had either of the distinct subtypes AML M2 with t(8;21), AML M3 or M3v with t(15;17), or AML M4eo with inv(16). Diagnosis was established by cytomorphology, cytogenetics, fluorescence in situ hybridization, and reverse transcriptase–PCR in every sample. By using two different strategies for microarray data analyses, this study revealed a unique correlation between AML-specific cytogenetic aberrations and gene expression profiles.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=126615Documentos Relacionados
- Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements
- Two Arabidopsis circadian oscillators can be distinguished by differential temperature sensitivity
- Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
- Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice
- Sequence-specific "gene signatures" can be obtained by PCR with single specific primers at low stringency.